These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 39093110)
1. Dosimetric effect of collimator rotation on intensity modulated radiotherapy and volumetric modulated arc therapy for rectal cancer radiotherapy. Abdulameer MS; Pallathadka H; Menon SV; Rab SO; Hjazi A; Kaur M; Sivaprasad GV; Husseen B; Al-Mualm M; Banaei A J Xray Sci Technol; 2024; 32(5):1331-1348. PubMed ID: 39093110 [TBL] [Abstract][Full Text] [Related]
2. Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer. Li MH; Huang SF; Chang CC; Lin JC; Tsai JT J Appl Clin Med Phys; 2018 Mar; 19(2):93-102. PubMed ID: 29322625 [TBL] [Abstract][Full Text] [Related]
3. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison. Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322 [TBL] [Abstract][Full Text] [Related]
4. Minimizing normal tissue low dose bath for left breast Volumetric Modulated Arc Therapy (VMAT) using jaw offset. Zhang Y; Fu W; Brandner E; Percinsky S; Moran M; Huq MS J Appl Clin Med Phys; 2024 Aug; 25(8):e14365. PubMed ID: 38760907 [TBL] [Abstract][Full Text] [Related]
5. Ninety-degree angled collimator: a dosimetric study related to dynamic intensity-modulated radiotherapy in patients with endometrial carcinoma. Serarslan A; Daştan Y; Aksu T; Yıldız RE; Gürsel B; Meydan D; Okumuş NÖ BMC Cancer; 2023 Jun; 23(1):515. PubMed ID: 37280543 [TBL] [Abstract][Full Text] [Related]
6. VMAT planning study in rectal cancer patients. Shang J; Kong W; Wang YY; Ding Z; Yan G; Zhe H Radiat Oncol; 2014 Oct; 9():219. PubMed ID: 25319073 [TBL] [Abstract][Full Text] [Related]
7. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy. Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536 [TBL] [Abstract][Full Text] [Related]
8. A dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer. Jeong Y; Lee SW; Kwak J; Cho I; Yoon SM; Kim JH; Park JH; Choi EK; Song SY; Kim YS; Kim SS; Joo JH; Ahn SD Radiat Oncol; 2014 Aug; 9():193. PubMed ID: 25175383 [TBL] [Abstract][Full Text] [Related]
9. Compared planning dosimetry of TOMO, VMAT and IMRT in rectal cancer with different simulated positions. Lin JC; Tsai JT; Chen LJ; Li MH; Liu WH Oncotarget; 2017 Jun; 8(26):42020-42029. PubMed ID: 28159930 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of fixed-jaw IMRT and tangential partial-VMAT radiotherapy plans for synchronous bilateral breast cancer irradiation based on a dosimetric study. Huang JH; Wu XX; Lin X; Shi JT; Ma YJ; Duan S; Huang XB J Appl Clin Med Phys; 2019 Sep; 20(9):31-41. PubMed ID: 31483573 [TBL] [Abstract][Full Text] [Related]
11. Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters. Taggar AS; Graham D; Kurien E; Gräfe JL J Appl Clin Med Phys; 2018 Jan; 19(1):276-281. PubMed ID: 29178585 [TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy, coplanar volumetric-modulated arc, therapy, and noncoplanar volumetric-modulated arc therapy in, glioblastoma: A dosimetric comparison. Hou Y; Zhang Y; Liu Z; Yv L; Liu K; Tian X; Lv Y Clin Neurol Neurosurg; 2019 Dec; 187():105573. PubMed ID: 31706107 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Comparison of Progressive Optimization Algorithm Based Automatic Plan and Manually Planned Treatment Technique for Cervical-Thoracic Esophageal Cancers. Zhou Y; Xiang X; Xiong J; Gong C Technol Cancer Res Treat; 2020; 19():1533033820973283. PubMed ID: 33176589 [TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy. Leung WS; Wu VWC; Liu CYW; Cheng ACK J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer. Kang SW; Kang S; Lee B; Song C; Eom KY; Jang BS; Kim IA; Kim JS; Cho W; Shin DS; Kim JY; Chung JB J Appl Clin Med Phys; 2022 Aug; 23(8):e13706. PubMed ID: 35727562 [TBL] [Abstract][Full Text] [Related]
17. Small-arc volumetric-modulated arc therapy: A new approach that is superior to fixed-field IMRT in optimizing dosimetric and treatment-relevant parameters for patients undergoing whole-breast irradiation following breast-conserving surgery. Yu J; Hu T; Chen Y Medicine (Baltimore); 2016 Aug; 95(34):e4609. PubMed ID: 27559956 [TBL] [Abstract][Full Text] [Related]
18. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients. Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936 [TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer. Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150 [TBL] [Abstract][Full Text] [Related]
20. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage. Karpf D; Sakka M; Metzger M; Grabenbauer GG Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]